- PB Fintech share price rebounded around 4% to ₹1,256 in early Friday trade after suffering a 36% collapse in the previous session.
- The selloff followed proposed IRDAI insurance commission rules that could materially change the economics of Policybazaar’s insurance distribution business.
- Brokerages remain divided after the crash, with Jefferies retaining Buy while HSBC and Motilal Oswal set ₹1,150 targets amid earnings uncertainty.
PB Fintech share price attempted a recovery on Friday, September 25, after the Policybazaar parent suffered its biggest one-day decline on record as investors reacted to proposed changes in India’s insurance distribution rules.
PB Fintech shares rose about 4% to ₹1,256 in early trade, after closing at ₹1,207.20 on Thursday. The rebound follows an extraordinary session in which the stock plunged 36% from its previous close of ₹1,886.30, hitting a fresh 52-week low.
Despite the recovery, the regulatory uncertainty that triggered Thursday’s selloff has not disappeared. Brokerages are now reassessing PB Fintech’s earnings outlook as investors wait to see how much of the Insurance Regulatory and Development Authority of India’s proposed framework survives the consultation process.
Why Did PB Fintech Share Price Fall 36%?
The PB Fintech share price crash followed an IRDAI consultation paper proposing significant changes to how insurers compensate distributors. The draft framework would introduce product- and channel-specific commission limits, potentially reducing payments across areas including health, motor and life insurance. That matters particularly for PB Fintech because its Policybazaar platform relies heavily on commissions generated through insurance distribution.
The market reaction was severe. PB Fintech lost more than ₹31,000 crore in market value during Thursday’s session, while other insurance-distribution stocks also came under pressure. Importantly, these are still draft proposals rather than final regulations. Stakeholders can submit comments until October 25, meaning the eventual framework could differ from the consultation paper.
IRDAI Rules Put Policybazaar Earnings Under Pressure
The biggest question now surrounding PB Fintech stock is how much the proposed commission changes could affect future earnings. Motilal Oswal estimates the rules could reduce PB Fintech’s FY28 core online insurance revenue by around 30%. In a downside scenario where lower revenue is not offset by cost reductions or other income, the brokerage estimates earnings could fall by as much as 46%.
Cost cuts could soften that impact. Motilal Oswal estimates that reducing employee and advertising expenses by around 20% could limit the potential earnings reduction to roughly 30%. Jefferies has also warned that the proposals could have a material effect on near-term earnings, particularly within PB Fintech’s non-life insurance operations. However, the brokerage retained its Buy rating while cutting its target price to ₹1,540.
PB Fintech Share Price Target After the Crash
Brokerage revisions have created a wide range of expectations for the PB Fintech share price target. HSBC downgraded PB Fintech to Hold and sharply reduced its target to ₹1,150 from ₹2,100. It also lowered its FY28 earnings-per-share estimate by 56% and its FY29 estimate by 17%.
Motilal Oswal maintained a Neutral rating and also set a ₹1,150 target, arguing that regulatory uncertainty could continue weighing on the stock until the final rules become clearer.
Jefferies is considerably more constructive. Its revised ₹1,540 target represents meaningful upside from Thursday’s closing price, although even the bullish view acknowledges that the proposed commission framework introduces significant uncertainty.
That divergence explains why PB Fintech remains one of the most closely watched Indian stocks following Thursday’s selloff.
PB Fintech Share Price Outlook: What Happens Next?
The immediate PB Fintech share price outlook will depend less on today’s rebound and more on what happens to the IRDAI proposals.
The consultation period running through October 25 gives insurers and distributors an opportunity to respond before the regulator moves toward a final framework. Any amendments to commission caps or implementation timelines could therefore materially change current earnings estimates.
For now, PB Fintech faces an unusual combination of a substantially lower share price and significantly higher regulatory uncertainty. Friday’s rebound shows buyers returning after the 36% fall, but the wide gap between brokerage forecasts suggests the market is still trying to determine what Policybazaar’s earnings could look like under the proposed rules.
PB Fintech shares rebounded around 4% to ₹1,256 in early Friday trading, following Thursday’s 36% collapse. The recovery comes after an exceptionally sharp selloff, although concerns over the proposed IRDAI commission rules remain.
Current brokerage targets vary considerably. HSBC and Motilal Oswal have targets of ₹1,150, while Jefferies has retained Buy with a revised ₹1,540 target. The wide range reflects uncertainty over the potential earnings impact of the proposed insurance rules
The next major catalyst is likely to be greater clarity on the IRDAI commission proposals. The consultation remains open until October 25, and changes to the final rules could alter current revenue and earnings estimates. Until then, regulatory developments are likely to remain an important driver of PB Fintech shares.